CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
25 hedge funds and large institutions have $407M invested in China Biologic Products Holdings, Inc. in 2014 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
74% less call options, than puts
Call options by funds: $212K | Put options by funds: $813K
Holders
25
Holding in Top 10
1
Calls
$212K
Puts
$813K
Top Buyers
| 1 | +$416K | |
| 2 | +$385K | |
| 3 | +$218K | |
| 4 |
VAM
Visium Asset Management
New York
|
+$162K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$87K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$460K | |
| 3 | -$395K | |
| 4 |
Two Sigma Investments
New York
|
-$237K |
| 5 |
SIM
Spark Investment Management
New York
|
-$211K |